Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
A Phase 2, Single-Arm, Open-Label, Multicenter Trial to Assess the Safety and Efficacy of MB-107 in Newly Diagnosed Infants with X-Linked Severe Combined Immunodeficiency
Complete Title: A Phase 2, Single-Arm, Open-Label, Multicenter Trial to Assess the Safety and Efficacy of MB-107 in Newly Diagnosed Infants with X-Linked Severe Combined Immunodeficiency
Trial Phase: II
Investigator: Kanwaldeep Mallhi
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
II
Kanwaldeep Mallhi
RG1121355
A Phase 2, Single-Arm, Open-Label, Multicenter Trial to Assess the Safety and Efficacy of MB-107 in Newly Diagnosed Infants with X-Linked Severe Combined Immunodeficiency